Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Anscare SIMO Negative Pressure Wound Therapy (NPWT) System

K-Number: K193185 · 2020-05-04

ApplicantBenq Materials Corporation
Decision Date2020-05-04
Product CodeOKO
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Anscare SIMO Negative Pressure Wound Therapy (NPWT) System is a medical device manufactured by Benq Materials Corporation. It received FDA 510(k) clearance on 2020-05-04 under approval number K193185. The device is classified under product code OKO. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Anscare SIMO Negative Pressure Wound Therapy (NPWT) System?

Anscare SIMO Negative Pressure Wound Therapy (NPWT) System is a medical device that received FDA 510(k) clearance on 2020-05-04. It is manufactured by Benq Materials Corporation. The 510(k) number is K193185.

When was Anscare SIMO Negative Pressure Wound Therapy (NPWT) System approved by the FDA?

Anscare SIMO Negative Pressure Wound Therapy (NPWT) System received FDA 510(k) clearance on 2020-05-04, under approval number K193185.

What company makes Anscare SIMO Negative Pressure Wound Therapy (NPWT) System?

Anscare SIMO Negative Pressure Wound Therapy (NPWT) System is manufactured by Benq Materials Corporation.

What is the FDA product code for Anscare SIMO Negative Pressure Wound Therapy (NPWT) System?

The FDA product code for Anscare SIMO Negative Pressure Wound Therapy (NPWT) System is OKO.

Related Clinical Trials

NCT01143558 Searching for Persistence of Infection in Lyme Disease COMPLETED NCT07475091 Standardizing Swallow Pressure Measurements NOT_YET_RECRUITING NCT07260890 Paired Comparison of SVV and PVI Accuracy COMPLETED NCT06011187 Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery COMPLETED NCT05016219 Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients RECRUITING NCT07235592 PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group RECRUITING

Related PubMed Literature

PMID: 41966529 Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load. Diagnostic microbiology and infectious disease (2026) PMID: 40942702 Digital Cardiovascular Twins, AI Agents, and Sensor Data: A Narrative Review from System Architecture to Proactive Heart Health. Sensors (Basel, Switzerland) (2025) PMID: 40775863 Use of the Learning Health System to Redesign and Implement a Clinical Decision Support System for Antimicrobial Stewardship. Studies in health technology and informatics (2025) PMID: 40624966 Peptide-Enhanced Bioactive Hydrogel Combined with Photodynamic-Phage Synergistic Antibacterial Therapy System Accelerates Infected Wound Healing. Advanced healthcare materials (2025)

Other Devices by Benq Materials Corporation

K242056miacare (DELiGHT daily wear/ DELiGHT 1-day/ CONFiDENCE Color daily wear/CONFiDENCE Color 1-day) Contact Lens with EautraSil Plus

Related Devices (Code: OKO)

K200305NPsealGuard Medical, Inc. K211130NPsealGuard Medical, Inc. K212971NPsealGuard Medical, Inc. K241522NPseal (20 and 25)Guard Medical, Inc. K240244NPseal (Small, Medium, Large)Guard Medical, Inc. K251156NPsealGuard Medical, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑